M3-Type muscarinic receptors predominantly mediate neurogenic quick contraction of bovine ciliary muscle

General Pharmacology

Volumn 30, Issue 4, 1998, Pages 579-584

  Masuda, Hiroshi ^a   Goto, Moritaka ^a   Tamaoki, Satoru ^a   Kamikawatoko, Soichiro ^b   Tokoro, Takashi ^b   Azuma, Hiroshi ^a  

^a Tokyo Med D   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

3H QNB binding; Bovine ciliary muscle; Eye focal accomodation; M1, M2, M3 muscarinic receptor subtypes; Neurogenic quick contraction; Transmural electrical stimulation

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ATROPINE; MUSCARINIC RECEPTOR; PHYSOSTIGMINE; PIRENZEPINE; RECEPTOR SUBTYPE; TETRODOTOXIN; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDINYL BENZILATE;

ACCOMMODATION; ANIMAL TISSUE; ARTICLE; BINDING SITE; CATTLE; CHOLINERGIC NERVE; CILIARY MUSCLE; CONTROLLED STUDY; ELECTROSTIMULATION; IN VITRO STUDY; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; ANIMAL; BINDING COMPETITION; CELL MEMBRANE; CILIARY BODY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANIMALS; BINDING, COMPETITIVE; CATTLE; CELL MEMBRANE; CILIARY BODY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; QUINUCLIDINYL BENZILATE; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC;

EID: 0032034205     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00312-1     Document Type: Article

References (23)

1. Azuma H., Masuda H., Sato J., Niwa K., Tokoro T. A possible role of endogenous inhibitor for nitric oxide synthesis in the bovine ciliary muscle. Exp. Eye Res. 64:1997;823-830.
2. Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmac. 35:1989;469-476.
3. 50) of an enzyme reaction. Biochem. Pharmac. 22:1973;3099-3108.
4. Choo L. K., Leung E., Mitchelson F. Failure of gallamine and pancuronium to inhibit selectively (-)-[3H] quinaclidinyl benzilate binding in guinea-pig atria. Can. J. Physiol. Pharmac. 63:1985;200-208.
5. Dorje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmac. Exp. Ther. 256:1991;727-733.
6. Gabelt B. T., Kaufman P. L. Inhibition of outflow facility, accommodative, and miotic responses to pilocarpine in rhesus monkeys by muscarinic receptor subtype antagonists. J. Pharmac. Exp. Ther. 263:1992;1133-1139.
7. Gabelt B. T., Kaufman P. L. Inhibition of aceclidine-stimulated outflow facility, accommodation and miosis in rhesus monkeys by muscarinic receptor antagonists. Exp. Eye Res. 58:1994;623-630.
8. Gilmartin B., Bullimore M. A., Rosenfield M., Winn B., Owens H. Pharmacological effects on accommodative adaptation. Optom. Vis. Sci. 69:1992;276-282.
9. Goyal R. K. Muscarinic receptor subtypes. Physiology and clinical implications N. Engl. J. Med. 321:1989;1022-1029.
10. Gupta N., Drance S. M., McAllister R., Prasad S., Rootman J., Cynader M. S. Localization of M3 muscarinic receptor subtype and mRNA in the human eye. Ophthalmol. Res. 26:1994;207-213. . a.
11. Gupta N., McAllister R., Drance S. M., Rootman J., Cynader M. S. Muscarinic receptor M1 and M2 subtypes in human eye. Br. J. Ophthalmol. 78:1994;555-559. . b.
12. Hammer R., Berrie C. P., Birdsall N. J. M., Burgen A. S. V., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 283:1980;90-92.
13. Jumblatt J. E., Hackmiller R. C. M2-type muscarinic receptors mediate prejunctional inhibition of norepinephrine release in the human iris-ciliary body. Exp. Eye Res. 58:1994;175-180.
14. Jumblatt J. E., Ohia S. E., Hackmiller R. C. Prejunctional modulation of norepinephrine release in the human iris-ciliary body. Invest. Ophthalmol. Vis. Sci. 34:1993;2790-2794.
15. Kamikawatoko S., Tokoro T., Azuma H., Hamasaki H., Ishida A. The effects of endothelin-1 on isolated bovine ciliary muscles. Exp. Eye Res. 61:1995;559-564.
16. Lazareno S., Roberts F. F. Measuring muscarinic antagonist potency using phosphoinositide breakdown in rat cortex slices. Br. J. Pharmac. 92:1987;677P.
17. Mallorga P., Babilon R.W., Buisson S., Surgue M. F. Muscarinic receptors of albino rabbit ciliary process. Exp. Eye Res. 48:1989;509-522.
18. 2 receptor antagonist, alone and in combination with atropine and gallamine. Eur. J. Pharmac. 144:1987;117-124.
19. Olmstead J. M. D. The role of the autonomic nervous system in accommodation for far and near vision. J. N. Merit. Dis. 99:1944;794-798.
20. Poyer J. F., Gabelt B. T., Kaufman P. L. The effect of muscarinic agonists and selective receptor subtype antagonists on the contractile response of the isolated rhesus monkey ciliary muscle. Exp. Eye Res. 59:1994;729-736.
21. Suzuki R. Neuronal influence on the mechanical activity of the ciliary muscle. Br. J. Pharmac. 78:1983;591-597.
22. Woldemussie E., Feldman B. J., Chen J. Characterization of muscarinic receptors in cultured human iris sphincter and ciliary muscle cells. Exp. Eye Res. 56:1993;385-392.
23. Zhang X., Hernandez M. R., Cheng M. C., Erickson-Lamy K. A. Further characterization of muscarinic receptor subtype mRNA in the human ciliary muscle. Invest. Ophthalmol. Vis. Sci. 33(Suppl.):1992;1200.